$AVIC and $BOCL: The Dean’s Swine Flu Stocks Still Have Juice
December 18th, 2009 at 9:28 am Posted by The Dean
This week, The Dean’s been teaching the CollegeStock Community about $AVIC and $BOCL and their potential to be swept away by Swine Flu Frenzy in the swine flu product market.
Since April, H1N1 has killed an estimated 10,000 people in the world, infecting 50 million and hospitalizing more than 200,000 in the United States. Sources such as Bloomberg have suggested that 90% of swine flu deaths were among people under the age of 65.
The Dean believes the viruses ability to knock literally anyone off their feet is a strong catalyst in the fear catalyst behind the H1N1 pandemic. In fact, The Dean believes this scary aspect has been confirmed with in a recent story of several players on the St. Louis Rams being infected with swine flu. While the team’s 1 and 12 record is hilarious, H1N1 has proven to not be a laughing matter at all.
Countries such Switzerland ordered what they felt was more than enough doses of the swine flu vaccines from producers, such as GlaxoSmithKline (NYSE: GSK) and Novartis (NYSE: NVS), and are looking to donate or sell their 4.5 million excess doses to the United States and other countries that are in need of the vaccine.
Some reports have suggested that the United States is learning from the H1N1 pandemic and will know how to deal with future outbreaks. But The Dean believes we’re not out of the woods yet. In fact, although Switzerland over-ordered vaccine doses, the country made sure to play their cards right and are making sure to have an ample supply on-hand in case of another outbreak.
While flu season technically hasn’t even started yet, and stock promoters like PennyStockChaser hot on The Dean’s swine flu trail, The Dean believes there’s plenty of pandemonium left for swine flu stocks like $AVIC and $BOCL to really heat up.
DEC 21 AVIC
0.21 -0.04 -16.00% 4,500